DMDG Open Meeting 2024
Ron Cooke Hub, University of York 133 Deramore Ln, York, United KingdomJoin Discovery Life Sciences at DMDG Open Meeting 2024 September 2-4, 2024 | University of York, York, England
FFPE tissues for gastric and gastroesophageal junction adenocarcinoma
These products are for Research Use Only. Not for use in diagnostic or therapeutic procedures.
Claudins (CLDN) are a family of transmembrane proteins and are present throughout the body. Among these proteins, CLDN18.2 is the dominant isoform in normal gastric tissue, and it is often retained in malignant transformation, making it an effective biomarker for identifying previously undefined population of patients with gastric or gastroesophageal junction (G/GEJ) adenocarcinoma.
Discovery Life Sciences has the world’s largest commercial biorepository and offers CLDN18.2 formalin-fixed, paraffin-embedded (FFPE) tissue samples.
CLDN18.2 FFPE Tissue Slide Set, Option 1 (Cat. No. 240221.1)
CLDN18.2 FFPE Tissue Slide Set, Option 2 (Cat. No. 240221.2)
Tumor content is confirmed via hematoxylin and eosin (H&E) staining. CLDN18.2 expression is determined by immunohistochemistry (IHC) staining using VENTANA CLDN18 (43-14A) Assay performed by Discovery’s Molecular Pathology division. All slides are freshly cut upon receipt of a PO.
Discovery Biomarker AcademyTM also offers CLDN18.2 IHC assay training classes and various post-approval studies, including concordance analysis.
Join Discovery Life Sciences at DMDG Open Meeting 2024 September 2-4, 2024 | University of York, York, England
Join Discovery Life Sciences at ECP 2024 September 7-11, 2024 | Spadolini Pavilion, Florence, Italy
Join Discovery Life Sciences at ESMO 2024 September 13-17, 2024 | Fira Barcelona Gran Via, Barcelona, Spain
Copyright © 2024 Discovery Life Sciences. All rights reserved.
Designed & Developed by Altitude Marketing